
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Plant Health Care Plc | LSE:PHC | London | Ordinary Share | GB00B01JC540 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.02 | -0.53% | 3.75 | 3.72 | 3.78 | 3.98 | 3.70 | 3.98 | 2,395,356 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pesticides, Agric Chems, Nec | 11.77M | -9.48M | -0.0278 | -1.33 | 12.64M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/11/2022 19:04 | The Plant Health Care team in Mexico participates in the Expo AgroAlimentaria Guanajuato ® which has a 62-hectare site, where its experimental field is exhibited with greenhouses and demonstration plots, as well as exhibition areas.phcmexico.com. | ![]() oapknob1 | |
07/11/2022 21:00 | Herds sleeping. But 1,000,000 and 600,000 trades maybe some are stirring. | ![]() oapknob1 | |
05/11/2022 12:23 | Pro Act in Spain Tweet. Plant Health Care continues with its promotion program at ProAct ® aa points of sale in the province of Almería and Granada. In the image, promotion carried out in Ejiberj El Ejido. | ![]() oapknob1 | |
28/10/2022 08:58 | Back door entrance. Once they see what Harpin can do (the impact is visible in 2-3 months), they’ll be back for the Pretec products. | ![]() pretax2 | |
28/10/2022 08:46 | Just me or is this significant The mutual recognition mechanism will help expand the use of Harpin ß in other European countries. | ![]() oapknob1 | |
28/10/2022 06:22 | Like these commentsThis is a major milestone for the Company. France is the largest agricultural producer in the European Union (EU) and this is the first registration of Harpin ß in Europe. France is one of the few countries in the EU which has a legal framework for biostimulant products. Harpin ß, under the trademark ProAct, has approval to commercialise in France until November 2030. Harpin ß is a recombinant protein that acts as a powerful biostimulant, improving the yield and quality of crops. The Company sells Harpin ß through specialist distributors around the world.The mutual recognition mechanism will help expand the use of Harpin ß in other European countries. Europe is the world's largest market for sustainable agriculture with annual sales of over $2 billion. | ![]() oapknob1 | |
28/10/2022 06:04 | Great news. | ![]() oapknob1 | |
28/10/2022 06:04 | RNS28 October 2022PLANT HEALTH CARE plc("Plant Health Care" or the "Company")Successful registration of Harpin ß in FrancePlant Health Care(R) (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce that Harpin ß has been successfully registered for use as a fertiliser in France by the Agence Nationale De Securitie Sanitaire (responsible for Food, Environmental and Occupational Health & Safety). | ![]() oapknob1 | |
28/10/2022 06:03 | RNS28 October 2022PLANT HEALTH CARE plc("Plant Health Care" or the "Company")Distributi | ![]() oapknob1 | |
27/10/2022 17:09 | It's a frustrating wait though | ![]() oapknob1 | |
27/10/2022 17:04 | I like this from the Interims re PHC279PHC279 is progressing through the regulatory process in the EPA (US Environmental Protection Agency), with approval expected in late Q4 2022. First commercial sales are expected in early 2023.It may slip to Q1 but we'll see. | ![]() oapknob1 | |
27/10/2022 16:52 | I need to double check in the next IMC call but my understanding is that most sales for Saorei in the current Brazil soy season will have been made before year end. I see that Cenkos has raised the tp from 31p to 33p and for me more important continue to see no need for a further equity raise. I note no comment on US approval for PHC279 and in theory no news is good news in that if they foresaw a delay they should have softened us up. | ![]() cerrito | |
27/10/2022 14:27 | I like this from the Interims re margins.Gross margin increased to 61% (H1 2021: 56%) | ![]() oapknob1 | |
27/10/2022 12:25 | pretax2, Decent response, thank you. I acknowledge that development is still on-going here. But it has been on-going for quite some time. I understanding promoting the products has a cost - but at some point we need to see margins holding and improving too - not declining as is currently the case. Best wishes, G. | ![]() garth | |
27/10/2022 11:43 | Running faster to stand still? At the moment the balance sheet is starting to tilt to profit, but slowly. That’s because of the promotional costs of the products, especially the new products. ProAct continues to be a success and is grooming growers. PHC are becoming a trusted brand and once their full platform is available I expect profits to dwarf costs. There’s a lot of ‘world’ for the PHC snowball to roll into, and new licenses are opening up the market to sustainable products. These days I ignore the shareprice if the fundamentals are showing promise, especially in a bear market. Value will out eventually, always does and usually when it’s least expected. | ![]() pretax2 | |
27/10/2022 10:17 | BlackSwann, materially ahead on revenues, underlying losses flat? Running faster to stand still? No position here, but the chart seems to be levelling out. Just a view. G. | ![]() garth | |
27/10/2022 07:12 | Come on PHC get the US approval sorted... | ![]() oapknob1 | |
27/10/2022 07:08 | It's a grower | ![]() oapknob1 | |
27/10/2022 06:13 | Great RNS this morning, materially ahead of revenue expectations! :) | blackswann | |
27/10/2022 06:13 | Update reads well.No mention of any delays and I do like 'materially ahead'. | ![]() geraldus | |
15/10/2022 07:21 | £8272.73 each. And CFO sold 220,000 shares at 9p £19800 double their money for "tax" purposes relating to exercising their options at 1p. | ![]() oapknob1 | |
14/10/2022 11:52 | So the two Jeffs now have a 'significant' holding at super nice price. Though in fairness JT did buy some on the open market recently. Nice to have the shares in sticky hands though. Companies I've known have a canny knack of getting the timing spot on with these option packages. Let's hope there's some truth to this, the chart tells it's own story. | ![]() pretax2 | |
06/10/2022 16:14 | PHC398 precedent | ![]() oapknob1 | |
06/10/2022 14:57 | Approval process is nothing to do with PHC and EPA do claim that Covid has left them behind. JT still confident of approval in Q4. | ![]() pretax2 | |
06/10/2022 10:52 | US approvals can't come soon enough. PHC and EPA (US Environmental Protection Agency) can't keep blaming COVID for the delay. | ![]() oapknob1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |